- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03644732
Atlas of Human Cognition by SEEG (MAPCOG-SEEG) (MAPCOG-SEEG)
Atlas of Human Cognition by SEEG
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The pre-surgical assessment of a cortectomy in patient suffering from a refractory epilepsy includes several examinations aiming both, to specify the epileptogenic zone (EZ) which must be resected and to evaluate functional and cognitive risks of surgery.
Nevertheless, in some patients, non-invasive evaluation does not give formal answer. In these subjects, it is then necessary to carry out a second step, consisting of an invasive exploration by implantation of intracerebral electrodes during a Stereoelectroencephalography (SEEG).
Due to its temporal and spatial resolution, the SEEG allows, besides the precise determination of the EZ, to carry out a functional mapping of the cortical regions likely to be included in cortectomy. Conventionally, this mapping is carried out on the basis of the cortical electrical stimulations applied to the implanted electrodes. If this approach is very robust for exploring primary functions such as motor skills or language, it cannot be used to evaluate more complex cognitive tasks such as face recognition or attention. Essential cognitive tasks on a daily basis.
This has led to the development in recent years, in Grenoble, of a complementary approach to cerebral stimulation: Dynamic Spectral Imaging (ISD). Numerous experimental paradigms have demonstrated that the realization of a cognitive task associates with the generation within the cortical regions involved in its treatment of a particular cortical activity. This activity is characterized by oscillations of the cortical rhythm in high frequencies (> 40 Hz), called gamma activities. The ISD thus consists in mapping this gamma activity during various cognitive tasks, thus making it possible to study more widely the complexity of the cognitive functions.
MAPCOG_SEEG aims to collect the cerebral recording of the patients who have performed this cognitive exploration to be able to in fine propose an Atlas of human cognition which takes advantage of the very rich information in terms of spatial and temporal resolution of the SEEG. Furthermore, it will exactly allow more to understand the impact of the epilepsy and the surgery of the epilepsy on the cognition.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Philippe Kahane, MD/PhD
- Phone Number: +33 476 765 488
- Email: pkahane@chu-grenoble.fr
Study Contact Backup
- Name: Marcela Perrone-Bertolotti, PhD
- Phone Number: +33 476 825 860
- Email: marcela.perrone-bertolotti@univ-grenoble-alpes.fr
Study Locations
-
-
-
Grenoble, France, 38043
- Recruiting
- University Hospital, Grenoble
-
Contact:
- Philippe Kahane, MD/PhD
- Phone Number: +33 476 765 488
- Email: pkahane@chu-grenoble.fr
-
Contact:
- Marcela Perrone-Bertolotti, PhD
- Phone Number: +33 476 825 860
- Email: marcela.perrone-bertolotti@univ-grenoble-alpes.fr
-
Nancy, France
- Recruiting
- CHRU Nancy
-
Contact:
- Louis MAILLARD
- Email: l.maillard@chru-nancy.fr
-
Paris, France, 75014
- Recruiting
- Hôpital Ste Anne
-
Contact:
- Philippe DOMENECH
- Email: philippe.domenech@inserm.fr
-
Contact:
- Estelle Pruvost-Robieux
- Email: e.pruvost@ghu-paris.fr
-
Rennes, France
- Recruiting
- CHU Rennes
-
Contact:
- Anca Nica
- Email: Anca.nica@chu-rennes.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Drug-resistant focal epilepsy
- Justified SEEG exploration in the context of presurgical assessment of epilepsy
- Written non-opposition to study participation
- Intellectual capacities compatible with the compliance in the cognitive tasks
Exclusion Criteria:
- Major Patient undergoing a legal protection measure or patient deprived of liberty as a result of a judicial or administrative decision
- Impossibility of collecting information on exposure (recent arrival in France, foreign language, etc.)
- Pregnant women (Contraindication to SEEG exploration)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
SEEG Group
Group with SEEG analysis (Pre-surgical SEEG assessment)
|
Visual and quantitative SEEG signal analysis.
As available, collection of behavioral and neuropsychological postsurgical data
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SEEG recordings using functional brain mapping procedure (composite measures)
Time Frame: 3 weeks
|
Prospective collection of data from SEEG recordings using functional brain mapping procedure performed in clinical routine during the presurgical assessment of patients with drug-resistant epilepsy.
These data are represented by the electroencephalographic activity during the realization of the different cognitive tasks proposed to the patients.
Electroencephalographic activity will then be analyzed in terms of Dynamic Spectral Imaging and in terms of high frequency activity ([50-150Hz]).
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavioral data (composite measures)
Time Frame: 3 weeks
|
Behavioral data (reaction time and accuracy of response) collected during the presurgical assessment (joint with the SEEG) and during the postsurgical follow-up (approximately 3 months after the surgery) as well as the collection of neuropsychological scores from the presurgical and postsurgical assessment. Behavioral performance and neuropsychological test scores before and after surgery (as available) will allow to evaluate the impact of surgery on cognitive functioning (improvement or deterioration of cognitive performance). |
3 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philippe Kahane, MD/PhD, University Hospital, Grenoble
- Study Chair: Marcela Perrone-Bertolotti, PhD, Centre National de la Recherche Scientifique, France
Publications and helpful links
General Publications
- Lachaux JP, Axmacher N, Mormann F, Halgren E, Crone NE. High-frequency neural activity and human cognition: past, present and possible future of intracranial EEG research. Prog Neurobiol. 2012 Sep;98(3):279-301. doi: 10.1016/j.pneurobio.2012.06.008. Epub 2012 Jun 26.
- Baciu M, Perrone-Bertolotti M. What do patients with epilepsy tell us about language dynamics? A review of fMRI studies. Rev Neurosci. 2015;26(3):323-41. doi: 10.1515/revneuro-2014-0074.
- Combrisson E, Perrone-Bertolotti M, Soto JL, Alamian G, Kahane P, Lachaux JP, Guillot A, Jerbi K. From intentions to actions: Neural oscillations encode motor processes through phase, amplitude and phase-amplitude coupling. Neuroimage. 2017 Feb 15;147:473-487. doi: 10.1016/j.neuroimage.2016.11.042. Epub 2016 Nov 30.
- Ossandon T, Vidal JR, Ciumas C, Jerbi K, Hamame CM, Dalal SS, Bertrand O, Minotti L, Kahane P, Lachaux JP. Efficient "pop-out" visual search elicits sustained broadband gamma activity in the dorsal attention network. J Neurosci. 2012 Mar 7;32(10):3414-21. doi: 10.1523/JNEUROSCI.6048-11.2012.
- Perrone-Bertolotti M, Vidal JR, de Palma L, Hamame CM, Ossandon T, Kahane P, Minotti L, Bertrand O, Lachaux JP. Turning visual shapes into sounds: early stages of reading acquisition revealed in the ventral occipitotemporal cortex. Neuroimage. 2014 Apr 15;90:298-307. doi: 10.1016/j.neuroimage.2013.12.027. Epub 2013 Dec 24.
- Perrone-Bertolotti M, Kujala J, Vidal JR, Hamame CM, Ossandon T, Bertrand O, Minotti L, Kahane P, Jerbi K, Lachaux JP. How silent is silent reading? Intracerebral evidence for top-down activation of temporal voice areas during reading. J Neurosci. 2012 Dec 5;32(49):17554-62. doi: 10.1523/JNEUROSCI.2982-12.2012.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38RC17.357
- 2017-A03248-45 (Other Identifier: ID RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Focal Epilepsy
-
Assistance Publique - Hôpitaux de ParisMedtronicRecruitingEpilepsy | Focal Epilepsy | Drug Resistant | Drug-resistant Focal Epilepsy | Epilepsies, FocalFrance
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
Peking Union Medical College HospitalGuidon Pharmaceutics Ltd.RecruitingRefractory Focal EpilepsyChina
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingDrug Resistant Epilepsy | Pediatrics | Epilepsies, FocalFrance
-
BiocodexRecruitingPharmacoresistant Focal EpilepsiesFrance
-
UCB Biopharma SRLTerminatedAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
UCB Biopharma S.P.R.L.PRA Health SciencesCompletedHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States
-
Neurocrine BiosciencesTerminatedFocal Onset Seizure | Focal Onset EpilepsySpain, Australia, Belgium, Czechia, France, Hungary, Italy
Clinical Trials on SEEG Group
-
The Cleveland ClinicCompleted
-
Duke UniversityChristian Doppler University HospitalEnrolling by invitationEpilepsy IntractableUnited States, Spain, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Japan, Romania, Switzerland
-
Baylor College of MedicineUniversity of Minnesota; University of TexasRecruitingDepression | EpilepsyUnited States
-
University Hospital, GrenobleUnknown
-
University Hospital, GenevaUniversity of Geneva, SwitzerlandNot yet recruiting
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
Xuanwu Hospital, BeijingCompleted
-
University Hospital, Strasbourg, FranceUnknownFocal Epilepsy | Refractory Epilepsy | Focal Cortical DysplasiaFrance
-
University Hospital, BordeauxRecruitingEpilepsy | Parkinson DiseaseFrance
-
Great Ormond Street Hospital for Children NHS Foundation...RecruitingEpilepsy | Epilepsy, Focal | Epilepsy, RefractoryUnited Kingdom